Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
67
datasets available to search
ShareScore release 0.9.0
Dataset results
67 results for “cediranib”
Best Approach in Recurrent-Ovarian-Cancer-with Cediranib-Olaparib
ClinicalTrials.gov study NCT03314740. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced Prostate Cancer
ClinicalTrials.gov study NCT02893917. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
ClinicalTrials.gov study NCT01391962. IPD Sharing: YES. Countries: 1. Publications: 4.
Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00278343. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
ClinicalTrials.gov study NCT00942877. IPD Sharing: YES. Countries: 1. Publications: 4.
Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00795340. IPD Sharing: NO. Countries: 2. Publications: 1.
Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT02502266. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
ClinicalTrials.gov study NCT00309946. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT01116648. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Pr
ClinicalTrials.gov study NCT02446600. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase o
ClinicalTrials.gov study NCT03660826. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cediranib Maleate With or Without Dasatinib in Patients With HRPC-Resistant to Treatment With Docetaxel
ClinicalTrials.gov study NCT01260688. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Cediranib in Combination With Lomustine Chemotherapy in Recurrent Glioblastoma
ClinicalTrials.gov study NCT00777153. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT01310855. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov study NCT01064648. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cediranib (AZD2171, RECENTIN™) in Metastatic or Recurrent Renal Cell Carcinoma
ClinicalTrials.gov study NCT00423332. IPD Sharing: Not stated. Countries: 2. Publications: 1.
The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).
ClinicalTrials.gov study NCT00385203. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT00399035. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?
ClinicalTrials.gov study NCT03570437. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
ClinicalTrials.gov study NCT02681237. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.